Global Search | Novartis

Hide Filters

Showing 1407 results

Media Library / Mar 01, 2024

Radioligand therapy (RLT) production line
Story / Apr 04, 2017

Loss of friend to liver cancer sharpens focus on experimental therapy

Discovery

A Novartis experimental drug in clinical trial aims to block liver cancer growth
Media Library / Aug 11, 2022

Gene Therapy Manufacturing in North Carolina
Media Library / Mar 01, 2024

Novartis radioligand therapy (RLT) manufacturing facility
Radioligand therapy: delivering now, building for the future
Press release / May 05, 2022

Novartis provides update on production of radioligand therapy medicines

Novartis has temporarily suspended production of Lutathera® and Pluvicto™/ 177Lu-PSMA-617 at facilities in Ivrea, Italy and Millburn, New JerseyThis action has been taken out of an abundance of…
Media Library / Mar 01, 2024

Specialized equipment for the manufacture of radioligand therapy (RLT)
Media Library / Mar 01, 2024

Refrigeration room at a Novartis radioligand therapy (RLT) manufacturing facility
Media Library / Mar 01, 2024

Quality control for environmental monitoring in radioligand therapy (RLT) manufacturing
Press release / Jun 02, 2018

New Novartis data presented at ASCO find nearly half of CML patients treated with Tasigna® remain in remission almost three years after stopping therapy

ENESTop and ENESTfreedom data evaluate Treatment-free Remission (TFR) rates at 144 weeks among eligible Ph+ CML-CP patients who stopped Tasigna® Findings further support durability and…